Progyny (PGNY) Tops Q3 EPS by 26c, provides guidance

Progyny (NASDAQ: PGNY) reported Q3 EPS of $0.40, $0.26 better than the analyst estimate of $0.14. Revenue for the quarter came in at $286.62 million versus the consensus estimate of $296.85 million.

GUIDANCE:

Progyny sees FY2024 EPS of $1.54-$1.57, versus the consensus of $1.57. Progyny sees FY2024 revenue of $1.135-1.15 billion, versus the consensus of $1.173 billion.

For earnings history and earnings-related data on Progyny (PGNY) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• Deutsche Bank Downgrades Spire Healthcare (SPI:LN) (SRRHF) to Hold
• UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy